In a 47-year-old woman with hypertension who is already on chlorthalidone and still has a diastolic blood pressure of 90 mm Hg or higher, what is the best drug to add next?

Add an ACE Inhibitor or ARB as the Next Drug

For this 47-year-old woman with uncontrolled hypertension on chlorthalidone monotherapy (DBP ≥90 mmHg), the best next step is to add either an ACE inhibitor or an ARB to her current thiazide-like diuretic. This represents standard step 2 therapy and is supported by the most recent and comprehensive hypertension guidelines.

Rationale Based on Current Guidelines

The 2024 ESC Guidelines 1 and 2025 AHA/ACC Guidelines 2, 3 provide the clearest direction here. Both emphasize that combination therapy with complementary mechanisms of action is the preferred approach when monotherapy fails to achieve blood pressure control. The evidence consistently shows that thiazide diuretics combined with RAS blockers (ACE inhibitors or ARBs) produce additive antihypertensive effects 4.

Why ACE Inhibitor or ARB?

• Age consideration: At 47 years old, she falls into the "under 55" category where RAS blockers are first-line agents 5
• Proven efficacy: The Veterans Affairs Single Drug Therapy Cooperative Study demonstrated that combinations including a thiazide diuretic were consistently more effective than combinations without diuretics, and adding an ACE inhibitor or ARB to an existing diuretic is a well-validated strategy 4
• Complementary mechanisms: Thiazide diuretics cause volume depletion while RAS blockers prevent compensatory activation of the renin-angiotensin system, making this combination particularly synergistic 4

Specific Drug Selection Algorithm

Choose an ACE inhibitor if:

• No history of ACE inhibitor-induced cough
• Not planning pregnancy (both ACE inhibitors and ARBs are contraindicated in pregnancy)
• Cost is a consideration (ACE inhibitors are generally less expensive)

Choose an ARB if:

• History of ACE inhibitor-induced cough
• Patient preference for potentially better tolerability
• Black ethnicity (ARBs may be slightly preferred over ACE inhibitors in this population) 6, 5

Alternative: Calcium Channel Blocker

The second-best option would be adding a dihydropyridine calcium channel blocker (CCB) such as amlodipine. The 2020 ISH Guidelines 6 and 2024 ESC Guidelines 1 both support the combination of thiazide diuretic plus CCB as an effective two-drug regimen. This combination is particularly useful if:

• The patient has contraindications to ACE inhibitors/ARBs
• There are compelling indications for CCB use (e.g., isolated systolic hypertension, elderly patients)

Dosing Considerations

Before adding a second agent, verify that chlorthalidone is at an adequate dose. The FDA label 7 indicates that if 25 mg daily is insufficient, the dose can be increased to 50 mg daily before adding a second drug. However, the 2008 AHA Scientific Statement 4 notes that chlorthalidone is superior to hydrochlorothiazide and should be preferentially used at 25 mg daily, which is equivalent to hydrochlorothiazide 50 mg.

The Preferred Triple Combination Path

Looking ahead, if blood pressure remains uncontrolled on two drugs, the universally recommended triple therapy is: ACE inhibitor or ARB + CCB + thiazide-like diuretic 4, 1, 4, 2, 3. This is why starting with either an ACE inhibitor/ARB or CCB as the second drug makes strategic sense—you're building toward this evidence-based triple combination.

Critical Monitoring Points

After adding the second agent:

• Recheck blood pressure within 2-4 weeks to assess response
• Monitor serum potassium and creatinine within 1-2 weeks if adding an ACE inhibitor or ARB (risk of hyperkalemia and acute kidney injury, especially if there's underlying renal disease)
• Target blood pressure: Aim for <130/80 mmHg per current guidelines 1, 2, 3
• Achieve target within 3 months of initiating or adjusting therapy 6

Common Pitfalls to Avoid

1. Don't combine two RAS blockers (ACE inhibitor + ARB)—this is explicitly not recommended due to increased risk of harm without additional benefit 1, 2
2. Don't add a beta-blocker as second-line therapy unless there are compelling indications (post-MI, heart failure, angina)—beta-blockers are not preferred for uncomplicated hypertension in this age group 1, 5, 8, 5
3. Don't switch away from chlorthalidone to hydrochlorothiazide—chlorthalidone provides superior 24-hour blood pressure control 4, 9
4. Don't delay treatment intensification—clinical inertia is a major contributor to uncontrolled hypertension

Single-Pill Combination Preference

The 2024 ESC 1 and 2025 AHA/ACC 2 guidelines strongly recommend fixed-dose single-pill combinations when using two-drug therapy to improve adherence. Consider prescribing a combination pill containing chlorthalidone plus an ACE inhibitor or ARB if available, though the 2008 AHA statement 4 notes that chlorthalidone is available in fewer fixed-dose combinations compared to hydrochlorothiazide.